Folate pathway disruption leads to critical disruption of methionine derivatives in mycobacterium tuberculosis

Chemistry and Biology

Volumn 21, Issue 7, 2014, Pages 819-830

  Nixon, Molly R ^a,b   Saionz, Kurt W ^c   Koo, Mi Sun ^e   Szymonifka, Michael J ^e   Jung, Hunmin ^c   Roberts, Justin P ^c   Nandakumar, Madhumita ^d   Kumar, Anuradha ^b   Liao, Reiling ^b   Rustad, Tige ^b   Sacchettini, James C ^c   Rhee, Kyu Y ^d   Freundlich, Joel S ^e   Sherman, David R ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^c TEXAS A AND M UNIVERSITY   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4,6 DIAMINO 1,2 DIHYDRO 2,2 DIMETHYL 1 [3 (2,4,5 TRICHLOROPHENOXY)PROPOXY] 1,3,5 TRIAZINE; BACTERIAL PROTEIN; DAPSONE; FOLIC ACID; FOLIC ACID ANTAGONIST; JSF 1187; MESSENGER RNA; META PROTEIN; METC PROTEIN; METH PROTEIN; METHIONINE; METHIONINE DERIVATIVE; S ADENOSYLMETHIONINE; SPEE PROTEIN; SULFAMETHOXAZOLE; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; DRUG POTENTIATION; GENE CONTROL; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

MYCOBACTERIUM TUBERCULOSIS;

EID: 84904643358     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2014.04.009     Document Type: Article

References (59)

1. S.I. Ahmad, S.H. Kirk, and A. Eisenstark Thymine metabolism and thymineless death in prokaryotes and eukaryotes Annu. Rev. Microbiol. 52 1998 591 625
2. S.G. Amyes, and J.T. Smith Trimethoprim action and its analogy with thymine starvation Antimicrob. Agents Chemother. 5 1974 169 178
3. G.R. Babu, and R. Laxminarayan The unsurprising story of MDR-TB resistance in India Tuberculosis (Edinb.) 92 2012 301 306
4. J. Barr A short history of dapsone, or an alternative model of drug development Pharm. Hist. 53 2011 123 147
5. B.R. Bloom, and C.J. Murray Tuberculosis: Commentary on a reemergent killer Science 257 1992 1055 1064
6. F. Boissier, F. Bardou, V. Guillet, S. Uttenweiler-Joseph, M. Daffé, A. Quémard, and L. Mourey Further insight into S-adenosylmethionine-dependent methyltransferases: Structural characterization of Hma, an enzyme essential for the biosynthesis of oxygenated mycolic acids in Mycobacterium tuberculosis J. Biol. Chem. 281 2006 4434 4445
7. B.M. Bolstad, R.A. Irizarry, M. Astrand, and T.P. Speed A comparison of normalization methods for high density oligonucleotide array data based on variance and bias Bioinformatics 19 2003 185 193
8. S.R. Bushby Synergy of trimethoprim-sulfamethoxazole Can. Med. Assoc. J. 112 1975 63 66
9. S. Chakraborty, T. Gruber, C.E. Barry 3rd, H.I. Boshoff, and K.Y. Rhee Para-aminosalicylic acid acts as an alternative substrate of folate metabolism in Mycobacterium tuberculosis Science 339 2013 88 91
10. S.T. Cole, R. Brosch, J. Parkhill, T. Garnier, C. Churcher, D. Harris, S.V. Gordon, K. Eiglmeier, S. Gas, and C.E. Barry 3rd et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence Nature 393 1998 537 544
11. L.J. Daniel, L.C. Norris, M.L. Scott, and G.F. Heuser Growth inhibition of bacteria by synthetic pterins: Studies with Streptococcus faecalis, Lactobacillus casei, and Lactobacillus arabinosus J. Biol. Chem. 169 1947 689 697
12. M.I. Dawson, D. O'Krongly, P.D. Hobbs, J.R. Barrueco, and F.M. Sirotnak Synthesis of the 7-hydroxy metabolites of methotrexate and 10-ethyl-10- deazaaminopterin J. Pharm. Sci. 76 1987 635 638
13. L.P. de Carvalho, S.M. Fischer, J. Marrero, C. Nathan, S. Ehrt, and K.Y. Rhee Metabolomics of Mycobacterium tuberculosis reveals compartmentalized co-catabolism of carbon substrates Chem. Biol. 17 2010 1122 1131
14. L.P. de Carvalho, H. Zhao, C.E. Dickinson, N.M. Arango, C.D. Lima, S.M. Fischer, O. Ouerfelli, C. Nathan, and K.Y. Rhee Activity-based metabolomic profiling of enzymatic function: Identification of Rv1248c as a mycobacterial 2-hydroxy-3-oxoadipate synthase Chem. Biol. 17 2010 323 332
15. M.V. Dias, P. Tyrakis, R.R. Domingues, A.F. Paes Leme, and T.L. Blundell Mycobacterium tuberculosis dihydrofolate reductase reveals two conformational states and a possible low affinity mechanism to antifolate drugs Structure 22 2014 94 103
16. G.B. Elion, S. Singer, and G.H. Hitchings Antagonists of nucleic acid derivatives: VIII. Synergism in combinations of biochemically related antimetabolites J. Biol. Chem. 208 1954 477 488
17. A.S. Fivian-Hughes, J. Houghton, and E.O. Davis Mycobacterium tuberculosis thymidylate synthase gene thyX is essential and potentially bifunctional, while thyA deletion confers resistance to p-aminosalicylic acid Microbiology 158 2012 308 318
18. N.R. Gandhi, A. Moll, A.W. Sturm, R. Pawinski, T. Govender, U. Lalloo, K. Zeller, J. Andrews, and G. Friedland Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa Lancet 368 2006 1575 1580
19. K.M. George, Y. Yuan, D.R. Sherman, and C.E. Barry 3rd The biosynthesis of cyclopropanated mycolic acids in Mycobacterium tuberculosis. Identification and functional analysis of CMAS-2 J. Biol. Chem. 270 1995 27292 27298
20. A.B. Gerum, J.E. Ulmer, D.P. Jacobus, N.P. Jensen, D.R. Sherman, and C.H. Sibley Novel Saccharomyces cerevisiae screen identifies WR99210 analogues that inhibit Mycobacterium tuberculosis dihydrofolate reductase Antimicrob. Agents Chemother. 46 2002 3362 3369
21. A. Gough, and G. Kaufman Pulmonary tuberculosis: Clinical features and patient management Nurs. Stand. 25 2011 48 56
22. N.M. Halliday, K.R. Hardie, P. Williams, K. Winzer, and D.A. Barrett Quantitative liquid chromatography-tandem mass spectrometry profiling of activated methyl cycle metabolites involved in LuxS-dependent quorum sensing in Escherichia coli Anal. Biochem. 403 2010 20 29
23. P.G. Hartman Molecular aspects and mechanism of action of dihydrofolate reductase inhibitors J. Chemother. 5 1993 369 376
24. J. Hirsch The "Sulfanilamide Effect" of Substances Devoid of Sulfo Groups Science 96 1942 139 140
25. F.M. Huennekens In search of dihydrofolate reductase Protein Sci. 5 1996 1201 1208
26. G. Huet, P. Constant, W. Malaga, M.A. Lanéelle, K. Kremer, D. van Soolingen, M. Daffé, and C. Guilhot A lipid profile typifies the Beijing strains of Mycobacterium tuberculosis: Identification of a mutation responsible for a modification of the structures of phthiocerol dimycocerosates and phenolic glycolipids J. Biol. Chem. 284 2009 27101 27113
27. T.R. Ioerger, Y. Feng, K. Ganesula, X. Chen, K.M. Dobos, S. Fortune, W.R. Jacobs Jr., V. Mizrahi, T. Parish, and E. Rubin et al. Variation among genome sequences of H37Rv strains of Mycobacterium tuberculosis from multiple laboratories J. Bacteriol. 192 2010 3645 3653
28. A.G. Karlson The in vitro activity of 4,4′-diaminodiphenyl sulfone against various acid-fast microorganisms Int. J. Lepr. 31 1963 183 187
29. I.M. Kompis, K. Islam, and R.L. Then DNA and RNA synthesis: Antifolates Chem. Rev. 105 2005 593 620
30. A. Kumar, K. Saigal, K. Malhotra, K.M. Sinha, and B. Taneja Structural and functional characterization of Rv2966c protein reveals an RsmD-like methyltransferase from Mycobacterium tuberculosis and the role of its N-terminal domain in target recognition J. Biol. Chem. 286 2011 19652 19661
31. A. Kumar, M. Zhang, L. Zhu, R.P. Liao, C. Mutai, S. Hafsat, D.R. Sherman, and M.W. Wang High-throughput screening and sensitized bacteria identify an M. tuberculosis dihydrofolate reductase inhibitor with whole cell activity PLoS One 7 2012 e39961
32. Y.K. Kwon, W. Lu, E. Melamud, N. Khanam, A. Bognar, and J.D. Rabinowitz A domino effect in antifolate drug action in Escherichia coli Nat. Chem. Biol. 4 2008 602 608
33. Y.K. Kwon, M.B. Higgins, and J.D. Rabinowitz Antifolate-induced depletion of intracellular glycine and purines inhibits thymineless death in E. coli ACS Chem. Biol. 5 2010 787 795
34. M.H. Lee, and G.F. Hatfull Mycobacteriophage L5 integrase-mediated site-specific integration in vitro J. Bacteriol. 175 1993 6836 6841
35. R. Li, R. Sirawaraporn, P. Chitnumsub, W. Sirawaraporn, J. Wooden, F. Athappilly, S. Turley, and W.G. Hol Three-dimensional structure of M. tuberculosis dihydrofolate reductase reveals opportunities for the design of novel tuberculosis drugs J. Mol. Biol. 295 2000 307 323
36. E. Liani, L. Rothem, M.A. Bunni, C.A. Smith, G. Jansen, and Y.G. Assaraf Loss of folylpoly-gamma-glutamate synthetase activity is a dominant mechanism of resistance to polyglutamylation-dependent novel antifolates in multiple human leukemia sublines Int. J. Cancer 103 2003 587 599
37. K. Minch, T. Rustad, and D.R. Sherman Mycobacterium tuberculosis growth following aerobic expression of the DosR regulon PLoS One 7 2012 e35935
38. C. Nathan, B. Gold, G. Lin, M. Stegman, L.P. de Carvalho, O. Vandal, A. Venugopal, and R. Bryk A philosophy of anti-infectives as a guide in the search for new drugs for tuberculosis Tuberculosis (Edinb.) 88 Suppl 1 2008 S25 S33
39. L. Nguyen, and C.J. Thompson Foundations of antibiotic resistance in bacterial physiology: The mycobacterial paradigm Trends Microbiol. 14 2006 304 312
40. H.D. Park, K.M. Guinn, M.I. Harrell, R. Liao, M.I. Voskuil, M. Tompa, G.K. Schoolnik, and D.R. Sherman Rv3133c/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis Mol. Microbiol. 48 2003 833 843
41. N. Parveen, and K.A. Cornell Methylthioadenosine/S-adenosylhomocysteine nucleosidase, a critical enzyme for bacterial metabolism Mol. Microbiol. 79 2011 7 20
42. J.J. Pesek, M.T. Matyska, M.T. Hearn, and R.I. Boysen Aqueous normal-phase retention of nucleotides on silica hydride columns J. Chromatogr. A 1216 2009 1140 1146
43. J.R. Piper, and J.A. Montgomery Preparation of 6-(bromomethyl)-2,4- pteridinediamine hydrobromide and its use in improved syntheses of methotrexate and related compounds J. Org. Chem. 42 1977 208 211
44. J. Plorde Sherris Medical Microbiology 2004 McGraw-Hill New York
45. S.J. Potts, D.J. Edwards, and R. Hoffman Challenges of target/compound data integration from disease to chemistry: A case study of dihydrofolate reductase inhibitors Curr. Drug Discov. Technol. 2 2005 75 87
46. A. Rahman, S.S. Srivastava, A. Sneh, N. Ahmed, and M.V. Krishnasastry Molecular characterization of tlyA gene product, Rv1694 of Mycobacterium tuberculosis: A non-conventional hemolysin and a ribosomal RNA methyl transferase BMC Biochem. 11 2010 35
47. M.C. Reddy, G. Kuppan, N.D. Shetty, J.L. Owen, T.R. Ioerger, and J.C. Sacchettini Crystal structures of Mycobacterium tuberculosis S-adenosyl-L-homocysteine hydrolase in ternary complex with substrate and inhibitors Protein Sci. 17 2008 2134 2144
48. A. Rosowsky Methotrexate analogs. 2. A facile method of preparation of lipophilic derivatives of methotrexate and 3′,5′- dichloromethotrexate by direct esterification J. Med. Chem. 16 1973 1190 1193
49. A. Rosowsky, G.P. Beardsley, W.D. Ensminger, H. Lazarus, and C.S. Yu Methotrexate analogues. 11. Unambiguous chemical synthesis and in vitro biological evaluation of alpha- and gamma-monoesters as potential prodrugs J. Med. Chem. 21 1978 380 386
50. T.R. Rustad, M.I. Harrell, R. Liao, and D.R. Sherman The enduring hypoxic response of Mycobacterium tuberculosis PLoS One 3 2008 e1502
51. D.P. Sangurdekar, Z. Zhang, and A.B. Khodursky The association of DNA damage response and nucleotide level modulation with the antibacterial mechanism of the anti-folate drug trimethoprim BMC Genomics 12 2011 583
52. A.A. Velayati, P. Farnia, M.R. Masjedi, T.A. Ibrahim, P. Tabarsi, R.Z. Haroun, H.O. Kuan, J. Ghanavi, P. Farnia, and M. Varahram Totally drug-resistant tuberculosis strains: evidence of adaptation at the cellular level Eur. Respir. J. 34 2009 1202 1203
53. C. Vilchèze, and W.R. Jacobs Jr. The combination of sulfamethoxazole, trimethoprim, and isoniazid or rifampin is bactericidal and prevents the emergence of drug resistance in Mycobacterium tuberculosis Antimicrob. Agents Chemother. 56 2012 5142 5148
54. R.J. Wallace Jr., D.R. Nash, L.C. Steele, and V. Steingrube Susceptibility testing of slowly growing mycobacteria by a microdilution MIC method with 7H9 broth J. Clin. Microbiol. 24 1986 976 981
55. B.J. Wards, and D.M. Collins Electroporation at elevated temperatures substantially improves transformation efficiency of slow-growing mycobacteria FEMS Microbiol. Lett. 145 1996 101 105
56. E.L. White, L.J. Ross, A. Cunningham, and V. Escuyer Cloning, expression, and characterization of Mycobacterium tuberculosis dihydrofolate reductase FEMS Microbiol. Lett. 232 2004 101 105
57. K.J. Williams, and K. Duncan Current strategies for identifying and validating targets for new treatment-shortening drugs for TB Curr. Mol. Med. 7 2007 297 307
58. A.E. Yeo, K.K. Seymour, K.H. Rieckmann, and R.I. Christopherson Effects of dual combinations of antifolates with atovaquone or dapsone on nucleotide levels in Plasmodium falciparum Biochem. Pharmacol. 53 1997 943 950
59. A. Zumla, A. George, V. Sharma, N. Herbert Baroness Masham of Ilton WHO's 2013 global report on tuberculosis: Successes, threats, and opportunities Lancet 382 2013 1765 1767